Europe Nucleotide Market Size & Outlook, 2023-2030
Europe nucleotide market, 2018-2030 (US$M)
Europe nucleotide market highlights
- The Europe nucleotide market generated a revenue of USD 203.4 million in 2023.
- The market is expected to grow at a CAGR of 6.9% from 2024 to 2030.
- In terms of segment, deoxy nucleotides was the largest revenue generating product in 2023.
- Deoxy Nucleotides is the most lucrative product segment registering the fastest growth during the forecast period.
Europe data book summary
| Market revenue in 2023 | USD 203.4 million |
| Market revenue in 2030 | USD 325.6 million |
| Growth rate | 6.9% (CAGR from 2023 to 2030) |
| Largest segment | Deoxy nucleotides |
| Fastest growing segment | Deoxy Nucleotides |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Deoxy Nucleotides |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche, Biorigin, DSM, Promega, Agilent Technologies Inc, ABF Ingredients |
Other key industry trends
- In terms of revenue, Europe region accounted for 23.9% of the global nucleotide market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 328.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nucleotide Market Scope
Nucleotide Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe nucleotide market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nucleotide market will help companies and investors design strategic landscapes.
Deoxy nucleotides was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe nucleotide market based on deoxy nucleotides covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted as one of the major markets for nucleotides, having market share of 26.8% of global volume consumed in 2018. Rising nucleotides demand owning to its widespread application such as in pharmaceuticals, animal feed additive and food & beverage sector is expected to propel market demand over the forecasted period.
The use of DNA chips and microarrays for diagnostic research is gaining popularity among researchers since they offer the opportunity to run thousands of samples simultaneously in a single experiment under virtually identical conditions.
The use of nucleotides in pharmaceutical sectors owing to its superior properties including enhanced immunity, positive effects on the intestines and positive effects of recovery from stress is expected to be a key driving factor for chemical’s market growth.
Reasons to subscribe to Europe nucleotide market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe nucleotide market databook
-
Our clientele includes a mix of nucleotide market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe nucleotide market , including forecasts for subscribers. This continent databook contains high-level insights into Europe nucleotide market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe nucleotide market
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
